179 related articles for article (PubMed ID: 36761204)
1. Chemerin levels in chronic kidney disease: A systematic review and meta-analysis.
Behnoush AH; Shobeiri P; Bahiraie P; Amirkhani N; Khalaji A; Peiman S
Front Endocrinol (Lausanne); 2023; 14():1120774. PubMed ID: 36761204
[TBL] [Abstract][Full Text] [Related]
2. High circulating endocan in chronic kidney disease? A systematic review and meta-analysis.
Khalaji A; Behnoush AH; Mohtasham Kia Y; Alehossein P; Bahiraie P
PLoS One; 2023; 18(8):e0289710. PubMed ID: 37556458
[TBL] [Abstract][Full Text] [Related]
3. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ren Q; Wang H; Zeng Y; Fang X; Wang M; Li D; Huang W; Xu Y
Lipids Health Dis; 2022 Mar; 21(1):27. PubMed ID: 35236351
[TBL] [Abstract][Full Text] [Related]
4. High serum chemerin level in CKD patients is related to kidney function, but not to its adipose tissue overproduction.
Blaszak J; Szolkiewicz M; Sucajtys-Szulc E; Konarzewski M; Lizakowski S; Swierczynski J; Rutkowski B
Ren Fail; 2015 Jul; 37(6):1033-8. PubMed ID: 25945605
[TBL] [Abstract][Full Text] [Related]
5. Serum Zinc Levels in Chronic Kidney Disease Patients, Hemodialysis Patients, and Healthy Controls: Systematic Review and Meta-Analysis.
Elgenidy A; Amin MA; Awad AK; Husain-Syed F; Aly MG
J Ren Nutr; 2023 Jan; 33(1):103-115. PubMed ID: 35472507
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle atrophy in clinical and preclinical models of chronic kidney disease: A systematic review and meta-analysis.
Troutman AD; Arroyo E; Sheridan EM; D'Amico DJ; Brandt PR; Hinrichs R; Chen X; Lim K; Avin KG
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):21-35. PubMed ID: 38062879
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Cognition in People With End-Stage Kidney Disease Treated With Hemodialysis: A Systematic Review and Meta-analysis.
O'Lone E; Connors M; Masson P; Wu S; Kelly PJ; Gillespie D; Parker D; Whiteley W; Strippoli GF; Palmer SC; Craig JC; Webster AC
Am J Kidney Dis; 2016 Jun; 67(6):925-35. PubMed ID: 26919914
[TBL] [Abstract][Full Text] [Related]
9. Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials.
Zheng HJ; Guo J; Wang Q; Wang L; Wang Y; Zhang F; Huang WJ; Zhang W; Liu WJ; Wang Y
Crit Rev Food Sci Nutr; 2021; 61(4):577-598. PubMed ID: 32329633
[TBL] [Abstract][Full Text] [Related]
10. Circulating apelin and chemerin levels in patients with polycystic ovary syndrome: A meta-analysis.
Gao Y; Xin C; Fan H; Sun X; Wang H
Front Endocrinol (Lausanne); 2022; 13():1076951. PubMed ID: 36714603
[TBL] [Abstract][Full Text] [Related]
11. Circulating apelin, chemerin and omentin levels in patients with gestational diabetes mellitus: a systematic review and meta-analysis.
Sun J; Ren J; Zuo C; Deng D; Pan F; Chen R; Zhu J; Chen C; Ye S
Lipids Health Dis; 2020 Feb; 19(1):26. PubMed ID: 32087711
[TBL] [Abstract][Full Text] [Related]
12. Chemerin: A biomarker for cardiovascular disease in diabetic chronic kidney disease patients.
Salama FE; Anass QA; Abdelrahman AA; Saeed EB
Saudi J Kidney Dis Transpl; 2016; 27(5):977-984. PubMed ID: 27752007
[TBL] [Abstract][Full Text] [Related]
13. Circulating chemerin level and the risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Rastkar M; Nikniaz L; Farhangi MA; Nikniaz Z
J Diabetes Metab Disord; 2023 Jun; 22(1):83-95. PubMed ID: 37255767
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of galectin-3 in chronic kidney disease patients: a systematic review and meta-analysis.
Zhang T; Cao S; Yang H; Li J
Int Urol Nephrol; 2019 Jun; 51(6):1005-1011. PubMed ID: 30963453
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone antagonists for people with chronic kidney disease requiring dialysis.
Hasegawa T; Nishiwaki H; Ota E; Levack WM; Noma H
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013109. PubMed ID: 33586138
[TBL] [Abstract][Full Text] [Related]
16. Circulating chemerin levels and gestational diabetes mellitus: a systematic review and meta-analysis.
Zhou Z; Chen H; Ju H; Sun M
Lipids Health Dis; 2018 Jul; 17(1):169. PubMed ID: 30041634
[TBL] [Abstract][Full Text] [Related]
17. Cognition in chronic kidney disease: a systematic review and meta-analysis.
Berger I; Wu S; Masson P; Kelly PJ; Duthie FA; Whiteley W; Parker D; Gillespie D; Webster AC
BMC Med; 2016 Dec; 14(1):206. PubMed ID: 27964726
[TBL] [Abstract][Full Text] [Related]
18. Salivary changes in chronic kidney disease and in patients undergoing hemodialysis: a systematic review and meta-analysis.
Rodrigues RPCB; Vidigal MTC; Vieira WA; Nascimento GG; Sabino-Silva R; Blumenberg C; Siqueira MF; Siqueira WL; Paranhos LR
J Nephrol; 2022 Jun; 35(5):1339-1367. PubMed ID: 35235185
[TBL] [Abstract][Full Text] [Related]
19. Cardiopulmonary reserve examined with cardiopulmonary exercise testing in individuals with chronic kidney disease: A systematic review and meta-analysis.
Pella E; Theodorakopoulou MP; Boutou AK; Alexandrou ME; Bakaloudi DR; Sarridou D; Boulmpou A; Papadopoulos C; Papagianni A; Sarafidis P
Ann Phys Rehabil Med; 2022 Sep; 65(5):101588. PubMed ID: 34634515
[TBL] [Abstract][Full Text] [Related]
20. Raised levels of chemerin in women with preeclampsia: A meta-analysis.
Xie Y; Quan X; Yang X
Biomol Biomed; 2024 May; 24(3):454-464. PubMed ID: 37782564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
